Paper33464409
The role of the glutamine transporter ASCT2 in antineoplastic therapy.
Teixeira E and 2 others. Cancer Chemother Pharmacol, 2021. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. The role of the glutamine transporter ASCT2 in antineoplastic therapy. Papers, record 33464409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33464409
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amino Acid Transport System ASC | Major topic |
| Glutamine | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Antibodies, Monoclonal | |
| Humans | |
| Minor Histocompatibility Antigens | |
| Oxidative Stress |
Source PubMed
References91
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27386546 | Fundamentals of cancer metabolism. | Sci Adv | 2016 | https://conductscience.org/library/papers/27386546 | PubMed |
| 2 | 31819178 | ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma. | Br J Cancer | 2020 | https://conductscience.org/library/papers/31819178 | PubMed |
| 3 | 28704361 | From Krebs to clinic: glutamine metabolism to cancer therapy. | Nat Rev Cancer | 2016 | https://conductscience.org/library/papers/28704361 | PubMed |
| 4 | 23999442 | Glutamine and cancer: cell biology, physiology, and clinical opportunities. | J Clin Invest | 2013 | https://conductscience.org/library/papers/23999442 | PubMed |
| 5 | 26054373 | Glutaminolysis and autophagy in cancer. | Autophagy | 2015 | https://conductscience.org/library/papers/26054373 | PubMed |
| 6 | 25855379 | Amino Acid transporters in cancer and their relevance to "glutamine addiction": novel targets for the design of a new class of anticancer drugs. | Cancer Res | 2015 | https://conductscience.org/library/papers/25855379 | PubMed |
| 7 | 31981058 | Amino Acid Transporters and Exchangers from the SLC1A Family: Structure, Mechanism and Roles in Physiology and Cancer. | Neurochem Res | 2020 | https://conductscience.org/library/papers/31981058 | PubMed |
| 8 | 31709772 | Anti-tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS-mutated human colorectal cancer cells. | Cancer Med | 2020 | https://conductscience.org/library/papers/31709772 | PubMed |
| 9 | 31535081 | Critical role of ASCT2-mediated amino acid metabolism in promoting leukaemia development and progression. | Nat Metab | 2019 | https://conductscience.org/library/papers/31535081 | PubMed |
| 10 | 30210919 | An anti-ASCT2 monoclonal antibody suppresses gastric cancer growth by inducing oxidative stress and antibody dependent cellular toxicity in preclinical models. | Am J Cancer Res | 2018 | https://conductscience.org/library/papers/30210919 | PubMed |
| 11 | 27865832 | Establishment of monoclonal antibodies against cell surface domains of ASCT2/SLC1A5 and their inhibition of glutamine-dependent tumor cell growth. | Biochem Biophys Res Commun | 2017 | https://conductscience.org/library/papers/27865832 | PubMed |
| 12 | 4768607 | Amino acid metabolism and its disorders. | Major Probl Clin Pediatr | 1973 | https://conductscience.org/library/papers/4768607 | PubMed |
| 13 | 26590711 | Cancer's Fuel Choice: New Flavors for a Picky Eater. | Mol Cell | 2015 | https://conductscience.org/library/papers/26590711 | PubMed |
| 14 | 4715268 | Testicular feminization. | Indian J Med Sci | 1973 | https://conductscience.org/library/papers/4715268 | PubMed |
| 15 | 28441384 | Hopefully devoted to Q: targeting glutamine addiction in cancer. | Br J Cancer | 2017 | https://conductscience.org/library/papers/28441384 | PubMed |
| 16 | 31100352 | Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer. | Semin Cell Dev Biol | 2020 | https://conductscience.org/library/papers/31100352 | PubMed |
| 17 | 26791262 | Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer. | World J Surg Oncol | 2016 | https://conductscience.org/library/papers/26791262 | PubMed |
| 18 | 25628363 | Regulation of mammalian nucleotide metabolism and biosynthesis. | Nucleic Acids Res | 2015 | https://conductscience.org/library/papers/25628363 | PubMed |
| 19 | 20832749 | Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. | Cancer Cell | 2010 | https://conductscience.org/library/papers/20832749 | PubMed |
| 20 | 21555572 | Pyruvate carboxylase is required for glutamine-independent growth of tumor cells. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21555572 | PubMed |
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42745749 | Metabolic reprogramming-related drug resistance in osteosarcoma: from molecular mechanisms to therapeutic translation. | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/42745749 | PubMed |
| 42733724 | Japanese encephalitis virus reprograms host pyrimidine metabolism to facilitate viral replication. | Infect Med (Beijing) | 2026 | https://conductscience.org/library/papers/42733724 | PubMed |
| 42519728 | Research progress in metabolic reprogramming and targeting metabolic pathways for clear cell renal cell carcinoma. | Genes Dis | 2026 | https://conductscience.org/library/papers/42519728 | PubMed |
| 42435173 | Epigenetics and One-Carbon Metabolism in Cancer: Mechanisms and Therapeutic Implications. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/42435173 | PubMed |
| 41898313 | Targeting the Glutamine Transporter SLC1A5 Enhances Sensitivity of Acute Myeloid Leukemia to MLN4924. | Biomedicines | 2026 | https://conductscience.org/library/papers/41898313 | PubMed |
| 40374895 | Yuanhuacine suppresses head and neck cancer growth by promoting ASCT2 degradation and inhibiting glutamine uptake. | Acta Pharmacol Sin | 2025 | https://conductscience.org/library/papers/40374895 | PubMed |
| 39844410 | Targeting Glutamine Metabolic Reprogramming in Pancreatic Cancer: Current Insights and Future Directions. | Curr Cancer Drug Targets | 2026 | https://conductscience.org/library/papers/39844410 | PubMed |
| 39308523 | Glutamine transporters as effective targets in digestive system malignant tumor treatment. | Oncol Res | 2024 | https://conductscience.org/library/papers/39308523 | PubMed |
| 39215845 | Glutamine and leukemia research: progress and clinical prospects. | Discov Oncol | 2024 | https://conductscience.org/library/papers/39215845 | PubMed |
| 39090116 | Emerging mechanisms and promising approaches in pancreatic cancer metabolism. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/39090116 | PubMed |
| 38972133 | Therapeutic implications of the metabolic changes associated with BRAF inhibition in melanoma. | Cancer Treat Rev | 2024 | https://conductscience.org/library/papers/38972133 | PubMed |
| 38844930 | Elevated SLC1A5 associated with poor prognosis and therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma. | J Transl Med | 2024 | https://conductscience.org/library/papers/38844930 | PubMed |
| 38670587 | Deregulated circRNAs in Epithelial Ovarian Cancer With Activity in Preclinical In Vivo Models: Identification of Targets and New Modalities for Therapeutic Intervention. | Cancer Genomics Proteomics | 2024 | https://conductscience.org/library/papers/38670587 | PubMed |
| 38571483 | Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1. | Pharm Biol | 2024 | https://conductscience.org/library/papers/38571483 | PubMed |
| 38432394 | Baicalein induces apoptosis by inhibiting the glutamine-mTOR metabolic pathway in lung cancer. | J Adv Res | 2025 | https://conductscience.org/library/papers/38432394 | PubMed |
| 38400818 | CircCPA4 induces ASCT2 expression to promote tumor property of non-small cell lung cancer cells in a miR-145-5p-dependent manner. | Thorac Cancer | 2024 | https://conductscience.org/library/papers/38400818 | PubMed |
| 37928274 | Glutamine metabolism controls amphiregulin-facilitated chemoresistance to cisplatin in human chondrosarcoma. | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/37928274 | PubMed |
| 37718764 | Bioinformatic Analysis of The Prognostic Value of A Panel of Six Amino Acid Transporters in Human Cancers. | Cell J | 2023 | https://conductscience.org/library/papers/37718764 | PubMed |
| 37655270 | Lobetyolin inhibits cell proliferation and induces cell apoptosis by downregulating ASCT2 in gastric cancer. | Cytotechnology | 2023 | https://conductscience.org/library/papers/37655270 | PubMed |
| 37298344 | Impact of Solute Carrier Transporters in Glioma Pathology: A Comprehensive Review. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37298344 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SLC1A5 | 6510 | PubTator's text mining | https://conductscience.org/library/genes/6510 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33464409
GET https://conductscience.org/api/papers/v1/33464409/references?page=2